The company had reported a net profit of Rs 102.12 crore in the same quarter of the previous fiscal.
However, its total income from operations during the quarter under review fell to Rs 1,215.35 crore, as against Rs 1,241.71 crore in the year-ago period, according to a regulatory filing.
"Despite a weak global economy, the company has performed well. The global agro sector continues to remain weak. The company is using this opportunity to accelerate qualifications of various new molecules for both agro and pharma sectors," SRF Managing Director Ashish Bharat Ram said.
The stock of SRF today settled at Rs 1,687.05, down 3.77 per cent from the previous close, on BSE.
Disclaimer: No Business Standard Journalist was involved in creation of this content
